Exploiting bacterial iron acquisition: Siderophore conjugates

Future Medicinal Chemistry

Volumn 4, Issue 3, 2012, Pages 297-313

  Ji, Cheng ^a   Juárez Hernández, Raúl E ^a   Miller, Marvin J ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

13C DESKETONEOENACTIN; AMINOPENICILLIN; AMPICILLIN; ANTIFUNGAL AGENT; ARTEMISININ; BETA LACTAM ANTIBIOTIC; CATECHOLATE; CEFALEXIN; CIPROFLOXACIN; DESFERRIDANOXAMINE; DESFERRISALMYCIN B; DESKETONEOENACTIN; FERRICHROME; FERRIOXAMINE; GRISEIN; HYDROXAMIC ACID; IRON CHELATING AGENT; LANTIBIOTIC; LORACARBEF; MICROCIN; MYCOBACTIN; ORNITHINE DERIVATIVE; ORNITHINE TRIHYDROXAMATE; POLYPEPTIDE ANTIBIOTIC AGENT; PYOCHELIN; PYOVERDINE; SIDEROMYCIN; SIDEROPHORE; TRICLOSAN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANAEROBIC FERMENTATION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL OUTER MEMBRANE; BURN; CANDIDA; CROSS LINKING; DIAGNOSTIC PROCEDURE; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STRUCTURE; DRUG TARGETING; DRUG TRANSPORT; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GROWTH INHIBITION; HUMAN; INFRARED SPECTROMETRY; IRON TRANSPORT; MALARIA; MICROORGANISM DETECTION; MULTIDRUG RESISTANCE; MYCOBACTERIUM VACCAE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN TRANSPORT; PSEUDOMONAS AERUGINOSA; REVIEW; SIDEROPHORE ANTIBIOTIC CONJUGATE; STREPTOMYCES VIOLACEUSNIGER; SYNTHESIS; TUBERCULOSIS;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIA; BACTERIAL INFECTIONS; FUNGI; HUMANS; IRON; IRON CHELATING AGENTS; MYCOSES; NANOCONJUGATES; SIDEROPHORES;

EID: 84863393586     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.11.191     Document Type: Review

References (59)

1. Miethke M, Marahiel MA. Siderophore-based iron acquisition and pathogen control. Microbiol. Mol. Biol. Rev. 71(3), 413-451 (2007).
2. Chu BC, Garcia-Herrero A, Johanson TH et al. Siderophore uptake in bacteria and the battle for iron with the host; a bird's eye view. Biometals 23(4), 601-611 (2010).
3. Crosa JH, Mey AR, Payne SM. Iron Transport in Bacteria. ASM Press, Washington, DC, USA (2004).
4. Crumbliss AL, Harrington JM. Iron sequestration by small molecules: thermodynamic and kinetic studies of natural siderophores and synthetic model compounds. In: Advances in Inorganic Chemistry, (Volume 61) Metal Ion Controlled Reactivity. Vaneldik R, Hubbard CD (Eds). Elsevier Academic Press Inc, San Diego, USA, 179-250 (2009).
5. Sandy M, Butler A. Microbial iron acquisition: marine and terrestrial siderophores. Chem. Rev. 109(10), 4580-4595 (2009).
6. Hider RC, Kong XL. Chemistry and biology of siderophores. Nat. Prod. Rep. 27(5), 637-657 (2010).
7. Braun V, Hantke K. Recent insights into iron import by bacteria. Curr. Opin Chem. Biol. 15(2), 328-334 (2011).
8. Wencewicz TA. Development of microbe-selective antibacterial agents: from small molecules to siderophores. PhD Dissertation, University of Notre Dame, IN, USA (2011).
9. Braun V, Pramanik A, Gwinner T, Koeberle M, Bohn E. Sideromycins: tools and antibiotics. Biometals 22(1), 3-13 (2009).
10. Roosenberg JM, Lin YM, Lu Y, Miller MJ. Studies and syntheses of siderophores, microbial iron chelators and analogs as potential drug delivery agents. Curr. Med. Chem. 7(2), 159-197 (2000).
11. Hartmann A, Fiedler HP, Braun V. Uptake and conversion of the antibiotic albomycin by Escherichia coli K-12. Eur. J. Biochem. 99(3), 517-524 (1979).
12. Braun V, Günthner K, Hantke K, Zimmermann L. Intracellular activation of albomycin in Escherichia coli and Salmonella typhimurium. J. Bacteriol. 156(1), 308-315 (1983).
13. Nolan EM, Walsh CT. Investigations of the MceIJ-catalyzed posttranslational modification of the microcin E492 C-terminus: linkage of ribosomal and nonribosomal peptides to form 'Trojan Horse' antibiotics. Biochemistry 47(35), 9289-9299 (2008).
14. Duquesne S, Destoumieux-Garzon D, Peduzzi J, Rebuffat S. Microcins, gene-encoded antibacterial peptides from enterobacteria. Nat. Prod. Rep. 24(4), 708-734 (2007).
15. Vertesy L, Aretz W, Fehlhaber HW, Kogler H. Salmycin A-D, antibiotics from streptomyces violaceus, DSM 8286 having a siderophore aminoglycoside structure. Helv. Chim. Acta 78(1), 46-60 (1995).
16. Roosenberg JM, Miller MJ. Total synthesis of the siderophore danoxamine. J. Org. Chem. 65(16), 4833-4838 (2000).
17. Dong L, Roosenberg JM, Miller MJ. Total synthesis of desferrisalmycin B. J. Am. Chem. Soc. 124(50), 15001-15005 (2002).
18. Möllmann U, Dong L, Vertesy L, Miller MJ. Salmycins-natural siderophore-drug conjugates: prospects for modification and investigation based on successful total synthesis. Presented at: The 2nd International Biometals Symposium. Garmisch-Partenkirchen, Germany (2004).
19. Wencewicz TA, Möllmann U, Long TE, Miller MJ. Is drug release necessary for antimicrobial activity of siderophore-drug conjugates? Syntheses and biological studies of the naturally occurring salmycin 'Trojan Horse' antibiotics and synthetic desferridanoxamine-antibiotic conjugates. Biometals 22(4), 633-648 (2009).
20. Bernier G, Girijavallabhan V, Murray A et al. Desketoneoenactin- siderophore conjugates for Candida: evidence of iron transport-dependent species selectivity. Antimicrob. Agents Chemo. 49(1), 241-248 (2005).
21. Irvin RT, Govan JW, Fyfe JA, Costerton JW. Heterogeneity of antibiotic-resistance in mucoid isolates of Pseudomonas aeruginosa obtained from cystic fibrosis patients: role of outer membrane proteins. Antimicrob. Agents Chemother. 19(6), 1056-1063 (1981).
22. Meynard JL, Barbut F, Guiguet M et al. Pseudomonas aeruginosa infection in human immunodeficiency virus infected patients. J. Infection 38(3), 176-181 (1999).
23. Nikaido H, Nikaido K, Harayama S. Identification and characterization of porins in Pseudomonas aeruginosa. J. Biol Chem. 266(2), 770-779 (1991).
24. Meyer JM, Stintzi A, Devos D et al. Use of siderophores to type pseudomonads: the three Pseudomonas aeruginosa pyoverdine systems. Microbiology 143, 35-43 (1997).
25. Kinzel O, Tappe R, Gerus I, Budzikiewicz H. The synthesis and antibacterial activity of two pyoverdin-ampicillin conjugates, entering Pseudomonas aeruginosa via the pyoverdin-mediated iron uptake pathway. J. Antibiotics 51(5), 499-507 (1998).
26. Ghosh A, Ghosh M, Niu C, Malouin F, Möllmann U, Miller MJ. Iron transport-mediated drug delivery using mixed-ligand siderophore-β-lactam conjugates. Chem. Biol. 3(12), 1011-1019 (1996).
27. Kinzel O, Budzikiewicz H. Synthesis and biological evaluation of a pyoverdin-β-lactam conjugate: a new type of arginine-specific crosslinking in aqueous solution. J. Pep. Res. 53(6), 618-625 (1999).
28. Hennard C, Truong QC, Desnottes JF, Paris JM, Moreau NJ, Abdallah MA. Synthesis and activities of pyoverdin-quinolone adducts: a prospective approach to a specific therapy against Pseudomonas aeruginosa. J. Med. Chem. 44(13), 2139-2151 (2001).
29. Ankenbauer R, Sriyosachati S, Cox CD. Effects of siderophores on the growth of Pseudomonas aeruginosa in human serum and transferrin. Infect. Immun. 49(1), 132-140 (1985).
30. Rivault F, Liebert C, Burger A et al. Synthesis of pyochelin-norfloxacin conjugates. Bioorg. Med. Chem. Lett. 17(3), 640-644 (2007).
31. Md-Saleh SR, Chilvers EC, Kerr KG et al. Synthesis of citrate-ciprofloxacin conjugates. Bioorg. Med. Chem. Lett. 19(5), 1496-1498 (2009).
32. Heinisch L, Wittmann S, Stoiber T, Berg A, Ankel-Fuchs D, Möllmann U. Highly antibacterial active aminoacyl penicillin conjugates with acylated bis-catecholate siderophores based on secondary diamino acids and related compounds. J. Med. Chem. 45(14), 3032-3040 (2002).
33. Heinisch L, Wittmann S, Stoiber T, Scherlitz-Hofmann I, Ankel-Fuchs D, Möllmann U. Synthesis and biological activity of tris-and tetrakiscatecholate siderophores based on poly-aza alkanoic acids or alkylbenzoic acids and their conjugates with β-lactam antibiotics. Arzneimittel Forschung Drug Res. 53(3), 188-195 (2003).
34. Wittmann S, Schnabelrauch M, Scherlitz-Hofmann I, Möllmann U, Ankel-Fuchs D, Heinisch L. New synthetic siderophores and their β-lactam conjugates based on diamino acids and dipeptides. Bioorg. Med. Chem. 10(6), 1659-1670 (2002).
35. Ohi N, Aoki B, Kuroki T, Matsumoto M, Kojima K, Nehashi T. Semisynthetic β-lactam antibiotics III. Effect on antibacterial activity and COMT-susceptibility of chlorine-introduction into the catechol nucleus of 6-(R)-2-3-(3,4-dihydroxybenzoyl)-3-(3-hydroxypropyl)-1-ureido-2-phenylacetamido penicillanic acid. J. Antibiotics 40(1), 22-28 (1987).
36. Yoganathan S, Sit CS, Vederas JC. Chemical synthesis and biological evaluation of gallidermin-siderophore conjugates. Org. Biomol. Chem. 9(7), 2133-2141 (2011).
37. Willey JM, Van Der Donk WA. Lantibiotics: peptides of diverse structure and function. Ann. Rev. Microbiol. 61, 477-501 (2007).
38. Kellner R, Jung G, Horner T et al. Gallidermin - a new lanthionine-containing polypeptide antibiotic. Eur. J. Biochem. 177(1), 53-59 (1988).
39. Miller MJ, Walz AJ, Zhu H et al. Design, synthesis, and study of a mycobactin-artemisinin conjugate that has selective and potent activity against tuberculosis and malaria. J. Am. Chem. Soc. 133(7), 2076-2079 (2011).
40. Kline T, Fromhold M, Mckennon TE et al. Antimicrobial effects of novel siderophores linked to β-lactam antibiotics. Bioorg. Med. Chem. 8(1), 73-93 (2000).
41. Buynak JD. The discovery and development of modified penicillin-and cephalosporin-derived β-lactamase inhibitors. Curr. Med. Chem. 11(14), 1951-1964 (2004).
42. Flanagan ME, Brickner SJ, Lall M et al. Preparation, Gram-negative antibacterial activity, and hydrolytic stability of novel siderophore-conjugated monocarbam diols. ACS. Med. Chem. Lett. 2(5), 385-390 (2011).
43. Han S, Zaniewski RP, Marr ES et al. Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 107(51), 22002-22007 (2010).
44. Mima T, Kvitko BH, Rholl DA, Page MGP, Desarbre E, Schweizer HP. In vitro activity of BAL30072 against Burkholderia pseudomallei. Int. J. Antimicrob. Agents 38(2), 157-159 (2011).
45. Page MGP, Dantier C, Desarbre E. In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant Gram-negative bacilli. Antimicrob. Agents Chemo. 54(6), 2291-2302 (2010).
46. Russo TA, Page MGP, Beanan JM et al. In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against Acinetobacter baumannii. J. Antimicrob. Chemo. 66(4), 867-873 (2011).
47. Barry AL, Thornsberry C, Jones RN, Gavan TL. Aztreonam-antibacterial activity β-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests. Rev. Infect. Dis. 7, S594-S604 (1985).
48. Jones RN, Barry AL, Thornsberry C, Fuchs PC, Packer RR. The antimicrobial activity, β-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam. Am. J. Clin. Pathol. 86(5), 608-618 (1986).
49. Rogers HJ, Woods VE, Synge C. Antibacterial effect of the scandium and indium complexes of enterochelin on Escherichia coli. J. Gen. Microbiol. 128, 2389-2394 (1982).
50. Kaneko Y, Thoendel M, Olakanmi O, Britigan BE, Singh PK. The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. J. Clin. Invest. 117(4), 877-888 (2007).
51. Banin E, Lozinski A, Brady KM et al. The potential of desferrioxamine-gallium as an anti-Pseudomonas therapeutic agent. Proc. Natl Acad. Sci. USA 105(43), 16761-16766 (2008).
52. Ding PY, Helquist P, Miller MJ. Design, synthesis and pharmacological activity of novel enantiomerically pure phosphonic acid-based NAALADase inhibitors. Org. Biomol. Chem. 5(5), 826-831 (2007).
53. Ding PY, Helquist P, Miller MJ. Design and synthesis of a siderophore conjugate as a potent PSMA inhibitor and potential diagnostic agent for prostate cancer. Bioorg. Med. Chem. 16(4), 1648-1657 (2008).
54. Ma YM, De Groot H, Liu ZD, Hider RC, Petrat F. Chelation and determination of labile iron in primary hepatocytes by pyridinone fluorescent probes. Biochem. J. 395, 49-55 (2006).
55. Ye Y, Bloch S, Xu B, Achilefu S. Novel near-infrared fluorescent integrin-targeted DFO analogue. Bioconj. Chem. 19(1), 225-234 (2008).
56. Ye Y, Bloch S, Kao J, Achilefu S. Multivalent carbocyanine molecular probes: synthesis and applications. Bioconj. Chem. 16(1), 51-61 (2005).
57. Bergeron RJ, Bharti N, Singh S, Mcmanis JS, Wiegand J, Green LG. Vibriobactin antibodies: a vaccine strategy. J. Med. Chem. 52(12), 3801-3813 (2009).
58. Doorneweerd DD, Henne WA, Reifenberger RG, Low PS. Selective capture and identification of pathogenic bacteria using an immobilized siderophore. Langmuir 26(19), 15424-15429 (2010).
59. Inomata T, Eguchi H, Matsumoto K, Funahashi Y, Ozawa T, Masuda H. Adsorption of microorganisms onto an artificial siderophore-modified Au substrate. Biosensors Bioelectronics 23(5), 751-755 (2007).